Warning: This security is no longer trading.
Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDerm
NeuroDerm Ltd. - (NDRM): Price and Financial Metrics
NDRM Price/Volume Stats
| Current price | $38.85 | 52-week high | $38.95 |
| Prev. close | $38.90 | 52-week low | $15.20 |
| Day low | $38.85 | Volume | 200,900 |
| Day high | $38.95 | Avg. volume | 418,712 |
| 50-day MA | $38.76 | Dividend yield | N/A |
| 200-day MA | $29.76 | Market Cap | 1.02B |
NDRM Stock Price Chart Interactive Chart >
NeuroDerm Ltd. - (NDRM) Company Bio
Neuroderm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhanced clinical efficacy through continuous, controlled administration. The company was founded in 2003 and is based in Rehovot, Israel.
NDRM Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...